Last reviewed · How we verify

ferumoxytol or oral iron

AMAG Pharmaceuticals, Inc. · Phase 3 active Small molecule

ferumoxytol or oral iron is a Iron replacement therapy Small molecule drug developed by AMAG Pharmaceuticals, Inc.. It is currently in Phase 3 development for Treatment of iron deficiency anemia in adult patients with chronic kidney disease.

Ferumoxytol is an intravenous iron replacement therapy that works by replenishing iron stores in the body.

Ferumoxytol is an intravenous iron replacement therapy that works by replenishing iron stores in the body. Used for Treatment of iron deficiency anemia in adult patients with chronic kidney disease.

At a glance

Generic nameferumoxytol or oral iron
SponsorAMAG Pharmaceuticals, Inc.
Drug classIron replacement therapy
ModalitySmall molecule
Therapeutic areaHematology
PhasePhase 3

Mechanism of action

It does this by being taken up by macrophages in the reticuloendothelial system, where it is stored and gradually released into the bloodstream, thereby increasing the body's iron levels. This helps to alleviate anemia in patients with iron deficiency. Ferumoxytol is a superparamagnetic iron oxide nanoparticle.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ferumoxytol or oral iron

What is ferumoxytol or oral iron?

ferumoxytol or oral iron is a Iron replacement therapy drug developed by AMAG Pharmaceuticals, Inc., indicated for Treatment of iron deficiency anemia in adult patients with chronic kidney disease.

How does ferumoxytol or oral iron work?

Ferumoxytol is an intravenous iron replacement therapy that works by replenishing iron stores in the body.

What is ferumoxytol or oral iron used for?

ferumoxytol or oral iron is indicated for Treatment of iron deficiency anemia in adult patients with chronic kidney disease.

Who makes ferumoxytol or oral iron?

ferumoxytol or oral iron is developed by AMAG Pharmaceuticals, Inc. (see full AMAG Pharmaceuticals, Inc. pipeline at /company/amag-pharmaceuticals-inc).

What drug class is ferumoxytol or oral iron in?

ferumoxytol or oral iron belongs to the Iron replacement therapy class. See all Iron replacement therapy drugs at /class/iron-replacement-therapy.

What development phase is ferumoxytol or oral iron in?

ferumoxytol or oral iron is in Phase 3.

What are the side effects of ferumoxytol or oral iron?

Common side effects of ferumoxytol or oral iron include Nausea, Headache, Diarrhea, Fatigue, Dizziness.

Related